World's Best Scientists 2026 revealed!
George N. Thalmann

George N. Thalmann

D-Index & Metrics

Medicine

D-Index
89
Citations
32058
World Ranking
12598
National Ranking
171

Overview

George N. Thalmann is affiliated with the University of Bern in Switzerland. Their research primarily covers medicine with specialized focus areas including surgery, pulmonary and respiratory medicine, cardiology and cardiovascular medicine, molecular biology, and oncology.

Their work spans several main topics in medical research:

  • Bladder and Urothelial Cancer Treatments
  • Prostate Cancer Treatment and Research
  • Urinary and Genital Oncology Studies
  • Cardiac Arrhythmias and Treatments
  • Prostate Cancer Diagnosis and Treatment
  • Urological Disorders and Treatments
  • Atrial Fibrillation Management and Outcomes

Frequent collaborators in their research include Marianna Kruithof-de Julio, Sofia Karkampouna, Federico La Manna, Thomas Kueffer, and Hildegard Tanner.

George N. Thalmann has published extensively in journals such as EP Europace, British Journal of Urology, The Journal of Urology, European Urology, and Cancer Research.

Their recent notable publications include:

  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines, 2020, European Urology
  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines, 2023, European Urology
  • The 2021 Updated European Association of Urology Guidelines on Metastatic Urothelial Carcinoma, 2021, European Urology
  • The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis, 2020, Cancers
  • Patient-derived xenografts and organoids model therapy response in prostate cancer, 2021, Nature Communications

Best Publications

  • Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

    Nicholas D. James;Nicholas D. James;Matthew R. Sydes;Noel W. Clarke;Malcolm David Mason

  • European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

    J. Alfred Witjes;Harman Max Bruins;Richard Cathomas;Eva M. Compérat

  • Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

    Christopher C Parker;Nicholas D James;Christopher D Brawley;Noel W Clarke

  • Radical Cystectomy for Bladder Cancer Today--A Homogeneous Series Without Neoadjuvant Therapy

    Stephan Madersbacher;Werner Hochreiter;Fiona Burkhard;George N. Thalmann

  • Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

    Roland Seiler;Roland Seiler;Hussam Al Deen Ashab;Nicholas Erho;Bas W G van Rhijn

  • An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    George van Andel;Andrew Bottomley;Sophie D. Fosså;Fabio Efficace

  • Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  • The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study.

    Agostino Mattei;Frank G. Fuechsel;Nivedita Bhatta Dhar;Sebastian H. Warncke

  • LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.

    George N. Thalmann;Robert A. Sikes;Tony T. Wu;Armelle Degeorges

  • High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer

    Christel van den Hoogen;Geertje van der Horst;Henry Cheung;Jeroen T. Buijs

  • Twenty Years Experience With an Ileal Orthotopic Low Pressure Bladder Substitute—Lessons to be Learned

    Urs E. Studer;Fiona C. Burkhard;Martin Schumacher;Thomas M. Kessler

  • Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

    Cora N Sternberg;Iwona Skoneczna;J Martijn Kerst;Peter Albers

  • Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines

    Tony T. Wu;Robert A. Sikes;Quanjun Cui;George N. Thalmann

  • Urinary diversion after radical cystectomy for bladder cancer: Options, patient selection, and outcomes

    Richard K. Lee;Hassan Abol-Enein;Walter Artibani;Bernard Bochner

  • Outcome After Radical Cystectomy With Limited or Extended Pelvic Lymph Node Dissection

    Nivedita Bhatta Dhar;Eric A. Klein;Alwyn M. Reuther;George N. Thalmann

  • Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer : a systematic review

    Guillaume Ploussard;Siamak Daneshmand;Jason A. Efstathiou;Harry W. Herr

  • Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)

    Francesco Soria;Francesco Soria;Shahrokh F. Shariat;Seth P. Lerner;Hans Martin Fritsche

  • PELVIC LYMPH NODE METASTASES FROM BLADDER CANCER: OUTCOME IN 83 PATIENTS AFTER RADICAL CYSTECTOMY AND PELVIC LYMPHADENECTOMY

    R.D. Mills;W.H. Turner;A. Fleischmann;R. Markwalder

  • Osteopontin: Possible Role in Prostate Cancer Progression

    George N. Thalmann;R. A. Sikes;R. E. Devoll;J. A. Kiefer

  • A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival

    Osama Shahin;George N. Thalmann;Cyrill Rentsch;L. Mazzucchelli

Frequent Co-Authors

Urs E. Studer
Urs E. Studer University of Bern
Nicholas D. James
Nicholas D. James Institute of Cancer Research
Arnulf Stenzl
Arnulf Stenzl University of Tübingen
David P. Dearnaley
David P. Dearnaley Institute of Cancer Research
Malcolm David Mason
Malcolm David Mason Cardiff University
Matthew R. Sydes
Matthew R. Sydes University College London
Noel W. Clarke
Noel W. Clarke University of Salford
Inti Zlobec
Inti Zlobec University of Bern
Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center
Chris Parker
Chris Parker Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Thinking about a future in healthcare but unsure if medical school is the right path? There are plenty of online degrees and alternative career options in the field. For those interested in patient care, some nursing schools with high acceptance rates make it more accessible to start a career in nursing. If you want to avoid lengthy entrance exams, you may also consider programs where you can find out, do I need to take the TEAS test for LPN.

For those who prefer administrative roles, consider a career in healthcare management with one of the healthcare administration degrees offered fully online. Or, explore in-demand positions as a medical coder with these medical billing and coding schools online with financial aid.

These flexible online options can help you begin a rewarding career in healthcare, whether you want to work with patients directly or support the industry behind the scenes.

Best Scientists Citing George N. Thalmann

Trending Scientists

Recently Published Articles